Zivo Bioscience (ZIVO) Gets a Buy From Maxim Group
Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
ZIVO Bioscience Reports Additional Findings From Positive 42-Day Coccidiosis Challenge Study
Reduction in intestinal damage enables poultry farms to optimize feed utilizationBLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D com
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has uplisted the trading of shares of its common stock from the OTC Pink Market to the OTCQB Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing
Mark E Strome, 10% Owner, on June 02, 2021, executed a purchase for 40,000 shares in Zivo Bioscience (ZIVO) for $199,600. Following the Form 4 filing with the SEC, Strome has control over a total of 2
ZIVO Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures,
Zivo Bioscience to Effect Reverse Stock Split to Regain Compliance With Nasdaq Rules
ZIVO Bioscience Announces Reverse Stock Split >ZIVO
ZIVO Bioscience Announces Reverse Stock Split >ZIVO
11 Consumer Staples Stocks Moving In Thursday's Intraday Session
GainersMeiwu Technology Co (NASDAQ:WNW) stock moved upwards by 45.1% to $0.14 during Thursday's regular session. As of 13:31 EST, Meiwu Technology Co's stock is trading at a volume of 108.5 million, w
Orchard Therapeutics, Longeveron Among Healthcare Movers
Zivo Bioscience to Offer Stock, Together With Warrants
Zivo Bioscience to Offer Stock, Together With Warrants
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
All test groups demonstrated statistically significant benefit in broiler health under simulated commercial conditions Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in
Zivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of Agreement
By Denny Jacob Zivo Bioscience said distributor ZWorldwide would purchase all supply of Zivolife for the first 18 months as part of a commercial agreement. The biotech/agtech research & development
ZIVO Announces Commitment by ZWorldwide to Purchase All Zivolife Algal Biomass Product Produced Over the Next 18 Months
ZWorldwide Commits to Minimum Annual Volume Purchases for Five Years ZIVO's Partner Alimenta Expects to Have Significantly Expanded Production Capacity Fully Operational in 2025 to Meet Projected Demand Zivo
Zivo Filed Prospectus For 2,996,260 Shares Of Common Stock Underlying Series A Common Warrants And Series B Common Warrants By Selling Stockholder
https://www.sec.gov/Archives/edgar/data/1101026/000165495423009761/zivo_s3.htm
ZIVO Commences Sales of Its Proprietary Algal Biomass as Human Food
Signs manufacturing agreement to grow and process algal biomass, enters into distribution agreement for branded DTC sales of ZivolifeTM Zivo Bioscience, Inc. (NASDAQ:ZIVO) ("ZIVO" or the "Company"), a biotech/agtech
Stocks That Hit 52-Week Lows On Monday
 On Monday morning, 70 companies achieved new lows for the year. Interesting Facts About Today's 52-Week Lows: Estee Lauder Cos (NYSE:EL) was the largest firm by market cap to set a new 52-week low
No Data